- Home
- Articles
- latamerica
- disease recurrence
Refine by
Disease Recurrence Articles & Analysis
11 articles found
Background and objective High grade serous carcinoma (HGSC) of the ovary is a complex and deadly disease. Although frontline treatment of chemotherapy and surgery is often effective, with nearly all patients experiencing remission, over 80% of patients will experience disease recurrence in the first two years and ultimately die of the ...
The intent for this procedure was to assess the treatment area, in part, using the NvisionVLE Imaging System, and to ablate any recurrence of ...
Results will inform protocol design of Phase 1/2 clinical trial of Company's lead HSV-2 therapeutic vaccine candidate WOBURN, Mass. and OXFORD, England, Aug. 15, 2022 /PRNewswire/ -- Rational Vaccines, a company focused on revolutionizing the treatment and prevention of herpes to eradicate the disease, today announced the launch of a clinical trial designed to determine the ...
On August 15, 2022, Rational Vaccines confirmed the observational clinical study, "A Study of the Characteristics of Patients Diagnosed With Recurrent Symptomatic Genital Herpetic Disease," with about 200 participants will be conducted at Southampton University Hospital and at Chelsea and Westminster Hospital, London, England. ...
Some patients with multiple myeloma often relapse due to the emergence of immune escape mutations, which makes cancer cells in the body resistant to therapy; therefore, researchers urgently need a new target antigen to develop a multi-targeted method, so as to avoid immune escape and avoid disease recurrence. In previous studies, researchers focused on ...
However, 40–50% of patients with DLBCL still present with intractable or recurrent disease and eventually die of progressive disease. Therefore, the treatment of DLBCL also needs to find more new therapeutic targets. ...
IORT using the Zeiss® Intrabeam® System has been proven to be non-inferior to External Beam Radiation Therapy (EBRT) in local recurrence and disease-free survival. IORT’s advantage is one treatment during surgery instead of several weeks of EBRT which has obvious benefits for patient convenience, compliance and quality of life. ...
Results Both VC2 and gD2 vaccines reduced acute genital disease. VC2 was somewhat more effective in reducing acute vaginal replication, the amount of virus in neural tissue, subsequent recurrent disease and recurrent virus shedding following challenge at 3 weeks post vaccination. ...
Furthermore, the total reservoir of latent virus in the trigeminal ganglia (TG), which supply sensory innervation to orofacial mucosal sites, correlates with reactivation risk and clinical disease burden in animal models.'7'11 Chronic viral reactivation in the human eye is associated with a myriad of clinically important corneal pathologies including scarring, neovascularization, ...
The guinea pig model allows evaluation of acute and recurrent disease, as well as vaginal shedding acutely and during episodes of recurrent activation. ...
Cancer therapy should aim to prevent recurrent disease. Surgery and toxic treatments remove only symptoms associated with cancer without trying to intervene in the aetiology, therefore the disease may recur. ...